Chlorine in PDB 6ne5: Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer
Protein crystallography data
The structure of Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer, PDB code: 6ne5
was solved by
B.Zhao,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
29.61 /
1.85
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
39.332,
135.942,
60.051,
90.00,
95.95,
90.00
|
R / Rfree (%)
|
17.2 /
20.7
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer
(pdb code 6ne5). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 8 binding sites of Chlorine where determined in the
Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer, PDB code: 6ne5:
Jump to Chlorine binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
Chlorine binding site 1 out
of 8 in 6ne5
Go back to
Chlorine Binding Sites List in 6ne5
Chlorine binding site 1 out
of 8 in the Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl400
b:0.6
occ:1.00
|
CL04
|
A:KJP400
|
0.0
|
0.6
|
1.0
|
C03
|
A:KJP400
|
1.8
|
70.4
|
1.0
|
C05
|
A:KJP400
|
2.8
|
58.5
|
1.0
|
C02
|
A:KJP400
|
2.8
|
48.1
|
1.0
|
O
|
A:ALA227
|
3.0
|
33.0
|
1.0
|
C34
|
A:KJP400
|
3.2
|
38.5
|
1.0
|
C
|
A:ALA227
|
3.2
|
33.0
|
1.0
|
CD1
|
A:PHE228
|
3.4
|
29.5
|
1.0
|
N
|
A:PHE228
|
3.4
|
31.2
|
1.0
|
CA
|
A:PHE228
|
3.6
|
29.0
|
1.0
|
CB
|
A:MET231
|
3.6
|
38.3
|
1.0
|
C32
|
A:KJP400
|
3.7
|
34.5
|
1.0
|
CB
|
A:ALA227
|
3.7
|
35.2
|
1.0
|
C35
|
A:KJP400
|
3.9
|
34.7
|
1.0
|
CE1
|
A:PHE228
|
4.0
|
29.6
|
1.0
|
C33
|
A:KJP400
|
4.0
|
30.7
|
1.0
|
CA
|
A:ALA227
|
4.0
|
35.7
|
1.0
|
C06
|
A:KJP400
|
4.2
|
45.7
|
1.0
|
CE
|
A:MET231
|
4.2
|
51.6
|
1.0
|
C01
|
A:KJP400
|
4.3
|
40.2
|
1.0
|
O
|
A:HOH558
|
4.3
|
41.5
|
1.0
|
CG
|
A:MET231
|
4.3
|
45.6
|
1.0
|
CG
|
A:PHE228
|
4.4
|
27.7
|
1.0
|
C36
|
A:KJP400
|
4.4
|
31.4
|
1.0
|
N30
|
A:KJP400
|
4.5
|
35.0
|
1.0
|
C
|
A:PHE228
|
4.6
|
31.5
|
1.0
|
CB
|
A:PHE228
|
4.6
|
27.5
|
1.0
|
N37
|
A:KJP400
|
4.6
|
35.8
|
1.0
|
CE1
|
A:PHE270
|
4.6
|
18.7
|
1.0
|
CD1
|
A:PHE270
|
4.7
|
16.6
|
1.0
|
SD
|
A:MET231
|
4.8
|
57.8
|
1.0
|
O
|
A:PHE228
|
4.8
|
29.3
|
1.0
|
C07
|
A:KJP400
|
4.8
|
37.6
|
1.0
|
CA
|
A:MET231
|
4.8
|
36.2
|
1.0
|
N
|
A:MET231
|
4.8
|
34.1
|
1.0
|
|
Chlorine binding site 2 out
of 8 in 6ne5
Go back to
Chlorine Binding Sites List in 6ne5
Chlorine binding site 2 out
of 8 in the Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl400
b:20.5
occ:1.00
|
CL22
|
A:KJP400
|
0.0
|
20.5
|
1.0
|
C21
|
A:KJP400
|
1.8
|
20.4
|
1.0
|
C23
|
A:KJP400
|
2.8
|
16.8
|
1.0
|
C28
|
A:KJP400
|
2.9
|
23.2
|
1.0
|
C24
|
A:KJP400
|
3.0
|
12.7
|
1.0
|
C29
|
A:KJP400
|
3.3
|
23.7
|
1.0
|
CE2
|
A:PHE270
|
4.0
|
21.8
|
1.0
|
CD1
|
A:LEU246
|
4.0
|
45.1
|
1.0
|
CB
|
A:LEU246
|
4.0
|
40.3
|
1.0
|
C25
|
A:KJP400
|
4.2
|
16.7
|
1.0
|
CE
|
A:MET250
|
4.2
|
36.8
|
1.0
|
CD2
|
A:PHE270
|
4.2
|
18.8
|
1.0
|
CD1
|
A:LEU235
|
4.2
|
30.0
|
1.0
|
C27
|
A:KJP400
|
4.2
|
21.4
|
1.0
|
CD2
|
A:LEU246
|
4.3
|
43.7
|
1.0
|
CG
|
A:LEU246
|
4.3
|
43.0
|
1.0
|
CG2
|
A:VAL274
|
4.4
|
19.4
|
1.0
|
CD1
|
A:LEU290
|
4.6
|
15.7
|
1.0
|
CG
|
A:MET250
|
4.7
|
34.3
|
1.0
|
C26
|
A:KJP400
|
4.7
|
17.3
|
1.0
|
O
|
A:LEU246
|
4.9
|
37.6
|
1.0
|
SD
|
A:MET250
|
4.9
|
33.9
|
1.0
|
|
Chlorine binding site 3 out
of 8 in 6ne5
Go back to
Chlorine Binding Sites List in 6ne5
Chlorine binding site 3 out
of 8 in the Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl400
b:18.8
occ:1.00
|
CL04
|
B:KJP400
|
0.0
|
18.8
|
1.0
|
C03
|
B:KJP400
|
1.7
|
20.7
|
1.0
|
C02
|
B:KJP400
|
2.7
|
20.8
|
1.0
|
C05
|
B:KJP400
|
2.8
|
19.6
|
1.0
|
C34
|
B:KJP400
|
3.0
|
23.2
|
1.0
|
O
|
B:ALA227
|
3.0
|
21.8
|
1.0
|
C
|
B:ALA227
|
3.4
|
23.1
|
1.0
|
C35
|
B:KJP400
|
3.5
|
18.2
|
1.0
|
CB
|
B:MET231
|
3.5
|
23.1
|
1.0
|
CD1
|
B:PHE228
|
3.6
|
16.5
|
1.0
|
C32
|
B:KJP400
|
3.7
|
23.0
|
1.0
|
N
|
B:PHE228
|
3.7
|
17.5
|
1.0
|
CE
|
B:MET231
|
3.8
|
47.3
|
1.0
|
C36
|
B:KJP400
|
3.8
|
14.5
|
1.0
|
CA
|
B:PHE228
|
3.8
|
18.7
|
1.0
|
CB
|
B:ALA227
|
3.9
|
21.4
|
1.0
|
O
|
B:HOH540
|
4.0
|
25.9
|
1.0
|
C01
|
B:KJP400
|
4.1
|
20.1
|
1.0
|
CE1
|
B:PHE228
|
4.2
|
16.9
|
1.0
|
CG
|
B:MET231
|
4.2
|
34.1
|
1.0
|
C06
|
B:KJP400
|
4.2
|
15.9
|
1.0
|
CA
|
B:ALA227
|
4.2
|
23.6
|
1.0
|
N37
|
B:KJP400
|
4.3
|
23.2
|
1.0
|
C33
|
B:KJP400
|
4.3
|
23.0
|
1.0
|
N30
|
B:KJP400
|
4.5
|
23.9
|
1.0
|
SD
|
B:MET231
|
4.6
|
47.5
|
1.0
|
CG
|
B:PHE228
|
4.6
|
17.1
|
1.0
|
C07
|
B:KJP400
|
4.7
|
16.0
|
1.0
|
C
|
B:PHE228
|
4.8
|
17.6
|
1.0
|
CA
|
B:MET231
|
4.8
|
20.8
|
1.0
|
CE1
|
B:PHE270
|
4.8
|
17.9
|
1.0
|
CB
|
B:PHE228
|
4.8
|
17.4
|
1.0
|
N
|
B:MET231
|
4.9
|
20.2
|
1.0
|
CD1
|
B:PHE270
|
4.9
|
15.3
|
1.0
|
O
|
B:PHE228
|
4.9
|
18.7
|
1.0
|
|
Chlorine binding site 4 out
of 8 in 6ne5
Go back to
Chlorine Binding Sites List in 6ne5
Chlorine binding site 4 out
of 8 in the Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl400
b:21.1
occ:1.00
|
CL22
|
B:KJP400
|
0.0
|
21.1
|
1.0
|
C21
|
B:KJP400
|
1.7
|
20.4
|
1.0
|
C23
|
B:KJP400
|
2.8
|
16.3
|
1.0
|
C28
|
B:KJP400
|
2.8
|
16.3
|
1.0
|
C24
|
B:KJP400
|
3.1
|
16.6
|
1.0
|
C29
|
B:KJP400
|
3.2
|
16.8
|
1.0
|
CD1
|
B:LEU246
|
3.7
|
25.5
|
1.0
|
CE
|
B:MET250
|
3.9
|
23.8
|
1.0
|
CB
|
B:LEU246
|
4.0
|
30.3
|
1.0
|
CD2
|
B:LEU246
|
4.1
|
27.3
|
1.0
|
CD1
|
B:LEU235
|
4.1
|
25.0
|
1.0
|
CG
|
B:LEU246
|
4.1
|
29.1
|
1.0
|
CE2
|
B:PHE270
|
4.2
|
18.5
|
1.0
|
C27
|
B:KJP400
|
4.2
|
16.1
|
1.0
|
C25
|
B:KJP400
|
4.2
|
16.2
|
1.0
|
CD2
|
B:PHE270
|
4.4
|
15.7
|
1.0
|
CG2
|
B:VAL274
|
4.6
|
11.9
|
1.0
|
CD1
|
B:LEU290
|
4.7
|
20.4
|
1.0
|
C26
|
B:KJP400
|
4.7
|
14.2
|
1.0
|
O
|
B:LEU246
|
4.8
|
31.5
|
1.0
|
CB
|
B:MET250
|
4.9
|
16.3
|
1.0
|
CG
|
B:MET250
|
4.9
|
21.6
|
1.0
|
|
Chlorine binding site 5 out
of 8 in 6ne5
Go back to
Chlorine Binding Sites List in 6ne5
Chlorine binding site 5 out
of 8 in the Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 5 of Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Cl400
b:37.2
occ:1.00
|
CL04
|
C:KJP400
|
0.0
|
37.2
|
1.0
|
C03
|
C:KJP400
|
1.8
|
22.9
|
1.0
|
C02
|
C:KJP400
|
2.8
|
20.1
|
1.0
|
C05
|
C:KJP400
|
2.8
|
17.5
|
1.0
|
C34
|
C:KJP400
|
3.1
|
20.8
|
1.0
|
O
|
C:ALA227
|
3.1
|
19.4
|
1.0
|
C
|
C:ALA227
|
3.4
|
20.5
|
1.0
|
CB
|
C:MET231
|
3.5
|
21.9
|
1.0
|
C35
|
C:KJP400
|
3.5
|
20.3
|
1.0
|
CD1
|
C:PHE228
|
3.6
|
17.3
|
1.0
|
N
|
C:PHE228
|
3.8
|
19.4
|
1.0
|
C32
|
C:KJP400
|
3.8
|
21.8
|
1.0
|
C36
|
C:KJP400
|
3.8
|
23.4
|
1.0
|
CA
|
C:PHE228
|
3.8
|
19.2
|
1.0
|
O
|
C:HOH551
|
3.8
|
24.3
|
1.0
|
CB
|
C:ALA227
|
3.9
|
21.8
|
1.0
|
CG
|
C:MET231
|
4.1
|
27.1
|
1.0
|
CE1
|
C:PHE228
|
4.2
|
18.7
|
1.0
|
C01
|
C:KJP400
|
4.2
|
18.5
|
1.0
|
C06
|
C:KJP400
|
4.2
|
16.8
|
1.0
|
CA
|
C:ALA227
|
4.2
|
21.8
|
1.0
|
CE
|
C:MET231
|
4.3
|
35.2
|
1.0
|
N37
|
C:KJP400
|
4.4
|
20.4
|
1.0
|
C33
|
C:KJP400
|
4.4
|
21.9
|
1.0
|
N30
|
C:KJP400
|
4.5
|
22.8
|
1.0
|
CG
|
C:PHE228
|
4.6
|
18.5
|
1.0
|
C07
|
C:KJP400
|
4.7
|
16.4
|
1.0
|
C
|
C:PHE228
|
4.8
|
19.5
|
1.0
|
CA
|
C:MET231
|
4.8
|
21.1
|
1.0
|
CE1
|
C:PHE270
|
4.8
|
17.0
|
1.0
|
CB
|
C:PHE228
|
4.8
|
19.0
|
1.0
|
N
|
C:MET231
|
4.8
|
19.9
|
1.0
|
CD1
|
C:PHE270
|
4.9
|
15.8
|
1.0
|
O
|
C:PHE228
|
4.9
|
21.4
|
1.0
|
SD
|
C:MET231
|
5.0
|
34.4
|
1.0
|
|
Chlorine binding site 6 out
of 8 in 6ne5
Go back to
Chlorine Binding Sites List in 6ne5
Chlorine binding site 6 out
of 8 in the Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 6 of Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Cl400
b:19.4
occ:1.00
|
CL22
|
C:KJP400
|
0.0
|
19.4
|
1.0
|
C21
|
C:KJP400
|
1.7
|
14.3
|
1.0
|
C23
|
C:KJP400
|
2.8
|
13.7
|
1.0
|
C28
|
C:KJP400
|
2.8
|
14.0
|
1.0
|
C24
|
C:KJP400
|
3.1
|
14.1
|
1.0
|
C29
|
C:KJP400
|
3.1
|
14.4
|
1.0
|
CD1
|
C:LEU246
|
3.8
|
19.7
|
1.0
|
CE
|
C:MET250
|
4.0
|
26.1
|
1.0
|
CD2
|
C:LEU246
|
4.0
|
19.2
|
1.0
|
CB
|
C:LEU246
|
4.0
|
21.3
|
1.0
|
CE2
|
C:PHE270
|
4.1
|
15.3
|
1.0
|
CD1
|
C:LEU235
|
4.1
|
23.7
|
1.0
|
CG
|
C:LEU246
|
4.1
|
21.0
|
1.0
|
C25
|
C:KJP400
|
4.2
|
13.2
|
1.0
|
C27
|
C:KJP400
|
4.2
|
13.5
|
1.0
|
CD2
|
C:PHE270
|
4.3
|
14.9
|
1.0
|
CG2
|
C:VAL274
|
4.7
|
13.4
|
1.0
|
C26
|
C:KJP400
|
4.7
|
13.8
|
1.0
|
CD1
|
C:LEU290
|
4.8
|
10.6
|
1.0
|
CG
|
C:MET250
|
4.8
|
24.6
|
1.0
|
O
|
C:LEU246
|
4.9
|
23.9
|
1.0
|
SD
|
C:MET250
|
5.0
|
26.3
|
1.0
|
|
Chlorine binding site 7 out
of 8 in 6ne5
Go back to
Chlorine Binding Sites List in 6ne5
Chlorine binding site 7 out
of 8 in the Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 7 of Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Cl400
b:19.1
occ:1.00
|
CL04
|
D:KJP400
|
0.0
|
19.1
|
1.0
|
C03
|
D:KJP400
|
1.7
|
17.9
|
1.0
|
C02
|
D:KJP400
|
2.7
|
20.1
|
1.0
|
C05
|
D:KJP400
|
2.8
|
18.9
|
1.0
|
C34
|
D:KJP400
|
3.0
|
21.8
|
1.0
|
O
|
D:ALA227
|
3.1
|
16.6
|
1.0
|
C
|
D:ALA227
|
3.4
|
16.9
|
1.0
|
CB
|
D:MET231
|
3.5
|
17.5
|
1.0
|
CD1
|
D:PHE228
|
3.5
|
12.8
|
1.0
|
C35
|
D:KJP400
|
3.5
|
19.0
|
1.0
|
N
|
D:PHE228
|
3.7
|
14.9
|
1.0
|
C32
|
D:KJP400
|
3.8
|
21.8
|
1.0
|
CA
|
D:PHE228
|
3.8
|
14.2
|
1.0
|
CB
|
D:ALA227
|
3.9
|
16.7
|
1.0
|
C36
|
D:KJP400
|
3.9
|
20.9
|
1.0
|
O
|
D:HOH544
|
4.0
|
20.6
|
1.0
|
CE1
|
D:PHE228
|
4.1
|
17.4
|
1.0
|
C01
|
D:KJP400
|
4.1
|
20.7
|
1.0
|
CG
|
D:MET231
|
4.1
|
25.9
|
1.0
|
CE
|
D:MET231
|
4.2
|
36.8
|
1.0
|
C06
|
D:KJP400
|
4.2
|
18.5
|
1.0
|
CA
|
D:ALA227
|
4.3
|
19.8
|
1.0
|
C33
|
D:KJP400
|
4.3
|
22.0
|
1.0
|
N37
|
D:KJP400
|
4.4
|
22.4
|
1.0
|
N30
|
D:KJP400
|
4.5
|
23.0
|
1.0
|
CG
|
D:PHE228
|
4.6
|
13.0
|
1.0
|
C07
|
D:KJP400
|
4.7
|
17.5
|
1.0
|
CE1
|
D:PHE270
|
4.7
|
15.7
|
1.0
|
C
|
D:PHE228
|
4.7
|
14.7
|
1.0
|
CB
|
D:PHE228
|
4.8
|
13.6
|
1.0
|
CD1
|
D:PHE270
|
4.8
|
15.0
|
1.0
|
CA
|
D:MET231
|
4.8
|
16.9
|
1.0
|
SD
|
D:MET231
|
4.8
|
37.5
|
1.0
|
O
|
D:PHE228
|
4.9
|
14.3
|
1.0
|
N
|
D:MET231
|
4.9
|
18.9
|
1.0
|
|
Chlorine binding site 8 out
of 8 in 6ne5
Go back to
Chlorine Binding Sites List in 6ne5
Chlorine binding site 8 out
of 8 in the Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 8 of Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Cl400
b:18.6
occ:1.00
|
CL22
|
D:KJP400
|
0.0
|
18.6
|
1.0
|
C21
|
D:KJP400
|
1.7
|
15.8
|
1.0
|
C23
|
D:KJP400
|
2.8
|
15.1
|
1.0
|
C28
|
D:KJP400
|
2.8
|
14.6
|
1.0
|
C24
|
D:KJP400
|
3.1
|
14.8
|
1.0
|
C29
|
D:KJP400
|
3.2
|
15.8
|
1.0
|
CD1
|
D:LEU246
|
3.6
|
17.1
|
1.0
|
CB
|
D:LEU246
|
4.0
|
17.8
|
1.0
|
CE
|
D:MET250
|
4.1
|
19.4
|
1.0
|
CE2
|
D:PHE270
|
4.1
|
18.8
|
1.0
|
C25
|
D:KJP400
|
4.1
|
16.8
|
1.0
|
CG
|
D:LEU246
|
4.2
|
17.3
|
1.0
|
C27
|
D:KJP400
|
4.2
|
15.5
|
1.0
|
CD1
|
D:LEU235
|
4.2
|
19.4
|
1.0
|
CD2
|
D:LEU246
|
4.2
|
17.3
|
1.0
|
CD2
|
D:PHE270
|
4.3
|
18.0
|
1.0
|
CG2
|
D:VAL274
|
4.6
|
13.8
|
1.0
|
C26
|
D:KJP400
|
4.7
|
15.5
|
1.0
|
CD1
|
D:LEU290
|
4.7
|
12.0
|
1.0
|
CG
|
D:MET250
|
4.7
|
19.2
|
1.0
|
|
Reference:
T.Lee,
P.P.Christov,
S.Shaw,
J.C.Tarr,
B.Zhao,
N.Veerasamy,
K.O.Jeon,
J.J.Mills,
Z.Bian,
J.L.Sensintaffar,
A.L.Arnold,
S.A.Fogarty,
E.Perry,
H.E.Ramsey,
R.S.Cook,
M.Hollingshead,
M.Davis Millin,
K.M.Lee,
B.Koss,
A.Budhraja,
J.T.Opferman,
K.Kim,
C.L.Arteaga,
W.J.Moore,
E.T.Olejniczak,
M.R.Savona,
S.W.Fesik.
Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer. J.Med.Chem. V. 62 3971 2019.
ISSN: ISSN 0022-2623
PubMed: 30929420
DOI: 10.1021/ACS.JMEDCHEM.8B01991
Page generated: Mon Jul 29 11:55:37 2024
|